ANSES scrutinises the diet of children under three years of age
Today the Agency is publishing an initial snapshot of dietary exposure of children under three years of age to a vast number of substances. The infant total diet study (iTDS) in fact covers more than 95% of the diet of babies and toddlers, with around 670 substances being analysed. This study confirmed the high level of health management regarding toxicity reference values, since a risk can be ruled out for most of the substances assessed. Some points, however, deserve particular attention: among the substances or classes of substances for which a risk could not be ruled out, 16 require a reduction in exposure, including nine considered a priority (heavy metals such as arsenic, or persistent organic pollutants such as PCBs, for example). ANSES is therefore recommending measures to reduce exposure of the infant population to these substances and acquire additional knowledge for refining risk assessments.
Reinforced measures for preventing mould growth in buildings and the impact of mould on human health
Today, ANSES publishes the results of its expert assessment of mould in buildings, a major issue for public health due to mould’s established effects on respiratory health, the large proportion of housing affected and the identification of population groups highly susceptible to developing pathologies when exposed. In its conclusions, the Agency recommends preventing mould in buildings first by reinforcing coordination between the sectors involved (construction, energy, etc.) and between the authorities and public entities, and second, through improved communication with housing occupants. The Agency also recommends preventing health problems, especially for the most vulnerable population groups, through changes in the regulations that would more effectively account for the risks of mould exposure in housing.
ANSES issues its conclusions regarding criteria for the identification of endocrine disruptors
In May 2016, ANSES received a formal request to propose criteria for defining endocrine disruptors (EDs). On 15 June 2016, while this request was being examined, the European Commission (EC) published a proposal for criteria for identifying EDs, which had been expected since late 2013. Today ANSES issues the results of its expert assessment, whose scope had to be modified to take into account the draft proposed by the Commission. In its conclusions, the Agency recommends retaining the definition and criteria for identifying EDs from Option 3 of the European Commission's 2014 roadmap, which enables EDs to be distinguished into three categories: "known", "presumed" and "suspected". In addition, the Agency recommends that classification of EDs be conducted by a single European body, to avoid any risk of divergence of classification for a given substance.
Publication of the report on occupational exposure to pesticides: a need for better understanding and a reduction in exposure
In France, more than a million professionals in the agricultural sector are potentially exposed to pesticides. In 2011, ANSES issued an internal request to conduct a collective expert appraisal aiming to identify, assess and characterise the exposure of agricultural workers to pesticides. In the opinion it has published, ANSES recommends decreasing exposure by reducing the use of pesticides, and issues various preventive measures. In addition, the Agency recommends improving understanding of exposure in actual conditions of use, in a context where the data available today are often in short supply.
ANSES organises a public consultation for its report on electromagnetic hypersensitivity
Today ANSES launches a public consultation of its draft report on electromagnetic hypersensitivity or idiopathic environmental intolerance attributed to electromagnetic fields. Members of the scientific community, physicians and interested stakeholders are invited to provide their comments on the pre-final report through an on-line public consultation which will be open through 30 September 2016. The Agency's objective is to gather additional scientific comments and data that can be taken into account in the final version of the expert assessment report.
ANSES calls for ceasing the use of VELACTIS® and recalling all batches, including from farms
Following several reports of serious adverse effects related to the veterinary drug VELACTIS ® , ANSES has suspended the use of this medicine. The Agency has asked veterinarians to no longer prescribe VELACTIS ® . A recall of all batches has been initiated and farmers are invited to return all unused products to their veterinarians.
Signature of a Memorandum of Understanding between ANSES and the National Institute of Food and Drug Safety Evaluation (NIFDS) of the Republic of Korea
During the visit to ANSES headquarters of a NIFDS delegation, the two Directors General, Dr. Yeowon SOHN and Dr. Roger GENET, signed a Memorandum of Understanding (MoU) on 12 July 2016. The signature of the MoU takes place during France-Korea year, 2015-2016, which celebrates 130 years of diplomatic relations between the two countries.
Exposure of children to radiofrequencies: a call for moderate and supervised use of wireless technologies
ANSES is today publishing an expert appraisal on the exposure of children to radiofrequencies and the potential effects on their health. In its conclusions, the Agency emphasises that children can be more exposed than adults because of their morphological and anatomical features, in particular their small size, as well as the characteristics of some of their tissues. It is issuing a series of recommendations aimed at adapting the regulatory limit values in order to reduce the exposure of children to electromagnetic fields, which starts from a very early age due to the expansion of the use of new technologies. In this context, ANSES recommends moderate and supervised use of wireless communication technologies by children.
New missions for ANSES concerning biocidal products
ANSES is today broadening its sphere of competence by taking over management of marketing authorisations (MAs) for biocidal products and responsibility for declarations to the biocidal products inventory (SIMMBAD). The Agency will build on the organisation it set up in July 2015 to issue marketing authorisations for plant protection products, while taking account of the specific features of the European regulation governing biocidal products. This regulation, applicable since 2013, seeks to ensure a high level of protection for humans, animals and the environment. In gaining these new missions, the Agency strengthens the integrative approach it has adopted in the area of chemical risk, with the aim of safeguarding consumers and the environment.